Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Sep
10
2018
Bhagat v. Iancu – Did the Myriad Decision Overrule Funk Bros.? Schwegman, Lundberg & Woessner, P.A.
Apr
25
2013
Google Provides its Suggestions to U.S. Patent and Trademark Office (USPTO) for Improving Software Patents Schwegman, Lundberg & Woessner, P.A.
Jan
26
2016
PTAB refuses attempt to kill ATM patent as claiming abstract idea: NRT Technology Corp. and NRT Technologies, Inc., Petitioner, v. Everi Payments, Inc., Patent Owner, CBM2015-00167 Schwegman, Lundberg & Woessner, P.A.
Jul
17
2013
Senator Leahy Urges National Institutes of Health (NIH) to Exercise “March-in” Rights on Myriad’s Tests Schwegman, Lundberg & Woessner, P.A.
Mar
29
2019
Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101 Schwegman, Lundberg & Woessner, P.A.
Oct
7
2023
Shenzhen Proposes Ending Patent Grant Subsidies Two Years Early Schwegman, Lundberg & Woessner, P.A.
Nov
27
2023
New Balance Scores 30 Million RMB in TM Infringement Case at China’s Supreme People’s Court Schwegman, Lundberg & Woessner, P.A.
Dec
6
2013
Australia – High Court Decision on Methods of Medical Treatment Schwegman, Lundberg & Woessner, P.A.
Apr
14
2016
Dave Kappos Calls for Abolition of Section 101 Schwegman, Lundberg & Woessner, P.A.
Apr
29
2016
Justice Breyer to Diagnostic Test Patentees – “Abandon Hope All Ye Who Enter Here.” Schwegman, Lundberg & Woessner, P.A.
Feb
26
2024
IP Tribunal of the Supreme People’s Court Releases Top 10 Influential Cases at 5-Year Anniversary of Founding Schwegman, Lundberg & Woessner, P.A.
Oct
29
2019
New China Patent Examination Guidelines Effective November 1, 2019 Schwegman, Lundberg & Woessner, P.A.
Dec
28
2019
Bruce Lee Enterprises, LLC Sues Chinese Fast Food Chain for IP Infringement Schwegman, Lundberg & Woessner, P.A.
Apr
28
2024
China’s Supreme People’s Court Releases Top 10 IP Cases of 2023 Schwegman, Lundberg & Woessner, P.A.
Jan
17
2020
CNIPA Announces Registration of Beijing 2022 Winter Olympics Mascots and Logos Schwegman, Lundberg & Woessner, P.A.
May
9
2024
5-Year Chinese Prison Sentence and 2 Million RMB Fine for Burberry Counterfeiter Schwegman, Lundberg & Woessner, P.A.
Sep
6
2016
District of Massachusetts Court Extends Myriad to Peptide Panels Schwegman, Lundberg & Woessner, P.A.
Oct
11
2016
Federal Circuit Affirms 101 Ineligibility of a Patent Claiming Detection of Unauthorized Access to Medical Information Schwegman, Lundberg & Woessner, P.A.
Jun
8
2020
The China National Intellectual Property Administration Announces Top 10 Patent Invalidation Cases of 2019 Schwegman, Lundberg & Woessner, P.A.
Aug
18
2020
China’s National People’s Congress Releases Second Draft of Amended Copyright Law Schwegman, Lundberg & Woessner, P.A.
Sep
8
2020
China’s State Administration for Market Regulation Releases Draft Provisions on the Protection of Trade Secrets Schwegman, Lundberg & Woessner, P.A.
Sep
17
2020
China and EU Sign Agreement to Protect Each Others’ Geographic Indications Schwegman, Lundberg & Woessner, P.A.
Oct
9
2020
China Releases Report on Development Status of the National Patent Agency Industry (2019) Schwegman, Lundberg & Woessner, P.A.
Nov
1
2020
Criminal Copyright Infringement of Alita Movie Leads to 4-Year Prison Sentence in China Schwegman, Lundberg & Woessner, P.A.
Oct
7
2014
“The Good Wife” Defends Genetically Modified Organisms (GMOs) Schwegman, Lundberg & Woessner, P.A.
Dec
29
2020
China’s National People’s Congress Passes Amended Criminal Law Adding an Economic Espionage Article and Increasing Prison Time for Intellectual Property Crimes Schwegman, Lundberg & Woessner, P.A.
Feb
21
2021
Burberry Wins Preliminary Injunction Against Baneberry at Suzhou, China’s Intermediate People’s Court for Trademark Infringement Schwegman, Lundberg & Woessner, P.A.
Dec
8
2014
Commil USA v. Cisco Systems – Induced Infringement In For Clarification Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins